Toutes les photos(1)

Key Documents

COO/COA

Autres documents

I9784

Monoclonal Anti-Insulin-like Growth Factor-II antibody produced in mouse

Name: Monoclonal Anti-Insulin-like Growth Factor-II antibody produced in mouse
Brand: SIGMA

clone 75015, purified immunoglobulin, lyophilized powder

Synonyme(s) :

Anti-IGF2, Anti-INSIGF

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Toutes les photos(1)

About This Item

Numéro MDL:

MFCD00162567

Code UNSPSC :

51111800

Nomenclature NACRES :

NA.41

Source biologique

mouse

Niveau de qualité

100

Conjugué

unconjugated

Forme d'anticorps

purified immunoglobulin

Type de produit anticorps

primary antibodies

Clone

75015, monoclonal

Forme

lyophilized powder

Espèces réactives

human

Technique(s)

neutralization: suitable

Isotype

IgG1

Numéro d'accès UniProt

P01344

Température de stockage

−20°C

Informations sur le gène

human ... IGF2(3481)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Immunogène

purified, E. coli-derived recombinant human insulin-like growth factor-II.

Actions biochimiques/physiologiques

Insulin-like growth factors -I and -II are important regulators of signaling that mediates growth and metabolism in cells. Insulin-like growth factor -II (IGF-II) is widely expressed during embryonic stages and regulates the placental development. IGF-II acts via specific receptor, IGF-IIR, the binding does not result in signal transduction, but is a mechanism to restrict the bioavailability of IGF-II. The effects of IGF-II signaling are important in growth of blood vessels (angiogenesis) gene transcription, proliferation and transformation.

Forme physique

Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline containing carbohydrates.

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Vous ne trouvez pas le bon produit ?

Essayez notre Outil de sélection de produits.

Produit(s) apparenté(s)

Réf. du produit

Description

Tarif

Code de la classe de stockage

13 - Non Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Équipement de protection individuelle

Eyeshields, Gloves, type N95 (US)

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.

Robert G Maki

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(33), 4985-4995 (2010-10-27)

Insulin-like growth factors were discovered more than 50 years ago as mediators of growth hormone that effect growth and differentiation of bone and skeletal muscle. Interest of the role of insulin-like growth factors in cancer reached a peak in the

IGF2: epigenetic regulation and role in development and disease.

Wendy Chao et al.

Cytokine & growth factor reviews, 19(2), 111-120 (2008-03-01)

Insulin-like growth factor II (IGF2) is perhaps the most intricately regulated of all growth factors characterized to date. Its gene is imprinted--only one allele is active, depending on parental origin--and this pattern of expression is maintained epigenetically in almost all

Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications.

C J Rosen

Clinical chemistry, 45(8 Pt 2), 1384-1390 (1999-08-03)

The last decade has been characterized by a major investigative thrust into the physiology of two unique but ubiquitous peptides, insulin-like growth factor (IGF)-I and IGF-II. The regulatory systems that control the tissue bioactivity of the IGFs have been delineated

Insulin-like growth factor system and sporadic malignant melanoma.

Ettore Capoluongo

The American journal of pathology, 178(1), 26-31 (2011-01-13)

Insulin and insulin-like growth factors (IGFs) are important regulators of energy metabolism and growth. Several findings have outlined an important role played by this family of molecules in both tumor maintenance and development. Despite the established contribution of the IGF

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique